Cited in:


This article has been cited by:

  1. 1
    David S. Robertson, A. Toby Prevost, Jack Bowden, Correcting for bias in the selection and validation of informative diagnostic tests, Statistics in Medicine, 2015, 34, 8
  2. 2
    S. Zhao, Y. Zheng, R. L. Prentice, Z. Feng, Two-stage biomarker panel study and estimation allowing early termination for futility, Biostatistics, 2015,


  3. 3
    Anthony E Rizzardi, Nikolaus K Rosener, Joseph S Koopmeiners, Rachel Isaksson Vogel, Gregory J Metzger, Colleen L Forster, Lauren O Marston, Jessica R Tiffany, James B McCarthy, Eva A Turley, Christopher A Warlick, Jonathan C Henriksen, Stephen C Schmechel, Evaluation of protein biomarkers of prostate cancer aggressiveness, BMC Cancer, 2014, 14, 1, 244


  4. 4
    Mei-Yin C. Polley, Eric C. Polley, Erich P. Huang, Boris Freidlin, Richard Simon, Two-stage adaptive cutoff design for building and validating a prognostic biomarker signature, Statistics in Medicine, 2014, 33, 29